Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Monte Rosa Therapeutics: Q3 Earnings Snapshot

AP - Contributor Content

This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here

BOSTON (AP) — BOSTON (AP) — Monte Rosa Therapeutics Inc. (GLUE) on Thursday reported a loss of $27.1 million in its third quarter.

The Boston-based company said it had a loss of 33 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 39 cents per share.

The biopharmaceutical company posted revenue of $12.8 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $7.8 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GLUE at https://www.zacks.com/ap/GLUE

Related Symbols

Symbol Last Chg %Chg
GLUE 16.56 -0.67 -3.89%
Monte Rosa Therapeutics Inc

Most Popular News

A Palantir sign displayed on an office building by Poetra_RH via Shutterstock 1
Palantir: The Future of Defense Contracts or DiamondCluster 2.0? What Michael Burry Has to Say About PLTR Stock.
Image of Mark Zuckerberg by Rokas Tenys via Shutterstock 2
Could Meta Stock Skyrocket in 2026 If Mark Zuckerberg Declares Another ‘Year of Efficiency’?
Chipset held over rush hour traffic by Jae Young Ju via iStock 3
Dear Micron Stock Fans, Mark Your Calendars for December 17
EV in showroom by Robert Way via Shutterstock 4
Why Nio Stock’s Probability Curve Points to a Hidden Upside Setup
Meta by creativeneko via Shutterstock 5
Is Google Stock a Buy Ahead of Its First AI Glasses Launch?
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot